Tech Company Financing Transactions
Cytek Biosciences Funding Round
On 11/6/2020, Cytek Biosciences raised $120 million in Series D funding from Hillhouse Capital Group, RA Capital and Lyfe Capital.
Transaction Overview
Company Name
Announced On
11/6/2020
Transaction Type
Venture Equity
Amount
$120,000,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the funds to expand its global infrastructure, sustain growth and deliver on its technology platform to offer expanded support for key areas of study such as immunotherapy, immuno-oncology and infectious diseases such as COVID-19.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
46107 Landing Pkwy.
Fremont, CA 94538
USA
Fremont, CA 94538
USA
Phone
Website
Email Address
Overview
Cytek Biosciences Inc. is a leading manufacturer and supplier of flow cytometry products and services. Cytek's compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Wenbin Jiang
Chief Financial Officer
Patrik Jeanmonod
Chief Technical Officer
Ming Yan
General Manager
Ken Riley
VP - Marketing
Mark Herberger
VP - Marketing
Gil Reinin
VP - Sales
Ray Lannigan
VP - Sales
Steve Ziganti
Browse more venture capital transactions:
Prev: 11/6/2020: Kobiton venture capital transaction
Next: 11/6/2020: ColdQuanta venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs